Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedRemoved the government funding status notice, a site-wide banner about potential delays and operating status, which is not part of the study specifics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe screenshots show no changes to the core study content (title, eligibility criteria, interventions, outcomes); only minor layout adjustments and updated timestamps are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check44 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference4%

- Check51 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check66 days agoChange DetectedUpdated to Revision v3.0.2 (replacing v3.0.1); removed the 'Back to Top' element.SummaryDifference0.2%

- Check73 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.